Bradley Foster & Sargent Inc Becton Dickinson & CO Transaction History

Bradley Foster & Sargent Inc

  • $5.82 Billion
  • Q3 2024

A detailed history of Bradley Foster & Sargent Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 26,452 shares of BDX stock, worth $6.04 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
26,452
Previous 44,515 40.58%
Holding current value
$6.04 Million
Previous $10.4 Million 38.7%
% of portfolio
0.11%
Previous 0.19%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024
SELL
$221.47 - $242.41 $4 Million - $4.38 Million
-18,063 Reduced 40.58%
26,452 $6.38 Million
Q2 2024

Aug 09, 2024
SELL
$225.07 - $246.17 $197,386 - $215,891
-877 Reduced 1.93%
44,515 $10.4 Million
Q1 2024

May 15, 2024
SELL
$233.45 - $247.73 $215,240 - $228,407
-922 Reduced 1.99%
45,392 $11.2 Million
Q4 2023

Feb 14, 2024
SELL
$232.24 - $267.23 $186,953 - $215,120
-805 Reduced 1.71%
46,314 $11.3 Million
Q2 2023

Aug 08, 2023
BUY
$238.39 - $265.32 $5.64 Million - $6.27 Million
23,648 Added 100.75%
47,119 $12.4 Million
Q1 2023

May 08, 2023
SELL
$229.71 - $259.35 $24,349 - $27,491
-106 Reduced 0.45%
23,471 $5.81 Million
Q4 2022

Feb 14, 2023
BUY
$218.29 - $256.91 $22,920 - $26,975
105 Added 0.45%
23,577 $6 Million
Q3 2022

Nov 14, 2022
SELL
$51.03 - $264.23 $67,767 - $350,897
-1,328 Reduced 5.35%
23,472 $5.23 Million
Q2 2022

Aug 11, 2022
BUY
$234.74 - $275.42 $35,915 - $42,139
153 Added 0.62%
24,800 $6.11 Million
Q1 2022

May 16, 2022
BUY
$243.64 - $270.48 $648,082 - $719,476
2,660 Added 12.1%
24,647 $6.56 Million
Q4 2021

Mar 11, 2022
SELL
$230.08 - $250.94 $3.2 Million - $3.49 Million
-13,894 Reduced 38.72%
21,987 $5.53 Million
Q3 2021

Nov 10, 2021
SELL
$232.72 - $256.47 $1.72 Million - $1.9 Million
-7,390 Reduced 17.08%
35,881 $8.82 Million
Q2 2021

Aug 19, 2021
SELL
$232.65 - $254.58 $289,416 - $316,697
-1,244 Reduced 2.79%
43,271 $10.5 Million
Q1 2021

Apr 26, 2021
SELL
$232.09 - $256.88 $22.4 Million - $24.8 Million
-96,395 Reduced 68.41%
44,515 $10.8 Million
Q4 2020

Feb 11, 2021
SELL
$221.92 - $245.94 $125,384 - $138,956
-565 Reduced 0.4%
140,910 $35.3 Million
Q3 2020

Oct 26, 2020
BUY
$215.77 - $276.76 $3.36 Million - $4.32 Million
15,593 Added 12.39%
141,475 $32.9 Million
Q1 2020

May 07, 2020
SELL
$195.69 - $279.01 $326,215 - $465,109
-1,667 Reduced 1.31%
125,882 $28.9 Million
Q4 2019

Jan 29, 2020
BUY
$236.45 - $266.82 $762,314 - $860,227
3,224 Added 2.59%
127,549 $34.7 Million
Q3 2019

Oct 30, 2019
SELL
$230.58 - $256.08 $461,621 - $512,672
-2,002 Reduced 1.58%
124,325 $31.4 Million
Q2 2019

Aug 08, 2019
BUY
$217.4 - $246.08 $2.2 Million - $2.49 Million
10,130 Added 8.72%
126,327 $31.8 Million
Q1 2019

May 02, 2019
BUY
$206.05 - $248.17 $888,693 - $1.07 Million
4,313 Added 3.85%
116,197 $29 Million
Q4 2018

Jan 30, 2019
BUY
$204.73 - $257.93 $17.6 Million - $22.2 Million
86,006 Added 332.35%
111,884 $25.2 Million
Q3 2018

Oct 31, 2018
BUY
$233.07 - $256.0 $413,699 - $454,400
1,775 Added 7.36%
25,878 $6.75 Million
Q2 2018

Jul 31, 2018
BUY
$208.1 - $233.85 $72,626 - $81,613
349 Added 1.47%
24,103 $5.77 Million
Q1 2018

May 07, 2018
BUY
$205.46 - $240.27 $31,846 - $37,241
155 Added 0.66%
23,754 $5.15 Million
Q4 2017

Feb 06, 2018
BUY
$189.0 - $222.64 $111,132 - $130,912
588 Added 2.56%
23,599 $5.05 Million
Q3 2017

Nov 03, 2017
BUY
$186.89 - $198.9 $4.3 Million - $4.58 Million
23,011
23,011 $4.51 Million

Others Institutions Holding BDX

# of Institutions
1,738
Shares Held
249M
Call Options Held
690K
Put Options Held
787K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Bradley Foster & Sargent Inc Portfolio

Follow Bradley Foster & Sargent Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bradley Foster & Sargent Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bradley Foster & Sargent Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email